期刊文献+

幽门螺杆菌感染对非甾体类抗炎药消化性溃疡转归的影响研究 被引量:3

EFFECT OF H. PYLORI INFECTION ON OUTCOME OF NON-STEROID ANTI-INFLAMMATORY DRUG IN PEPTIC ULCER
下载PDF
导出
摘要 目的探讨幽门螺杆菌(H.pylori,Hp)感染对非甾体类抗炎药(non-steroidal inflammatory dugys,NSAIDs)消化性溃疡(PU)转归的影响。方法400例确诊NSAIDs消化性溃疡和感染Hp患者按配对分组法分为根除Hp感染组(根除组)200例、单纯抑酸治疗组(抑酸组)200例。患者在研究治疗期间暂停服用NSAIDs。根除组予奥美拉唑(商品名:洛赛克)20mg,2次/d,克拉霉素0.5g,2次/d,羟氨苄阿莫西林1.0g,2次/d,共1周。第二至第八周予洛赛克20mg/d。抑酸组予洛赛克20mg/d共8周。二组患者在治疗后1个月、24个月进行胃镜和Hp复查,对比其溃疡的愈合率、复发率、并发症发生率情况。结果根除组Hp的根除率为98%,二组溃疡愈合率差异无统计学意义(85.7%比88.0%,P>0.05),2年内溃疡复发率:抑酸组明显低于根除组(26.5%比12.0%,P<0.05);胃溃疡(GU)并出血发生率:抑酸组明显低于根除组(28.1%比15.5%,P<0.05);十二指肠溃疡(DU)并出血发生率:二组差异无统计学意义(10.7%比9.5%,P>0.05)。结论Hp和NSAIDs是消化性溃疡发生的二个重要独立危险因素,二者间无相加或协同作用。Hp感染并不影响NSAIDs性溃疡的愈合,并且可能降低其近期的复发率。Hp感染与NSAIDs胃溃疡引起出血呈明显反比关系,而与十二指肠出血无关。 Objective To approach the effect of H. pylori (Hp) infection on outcome of patients with peptic ulcer treated by nonsteroidal anti- inflammatory drugs (NSAIDs). Methods 400 patients with peptic ulcer and Hp infection were divided into Hp eradication group (200 cases) and antacid group (200 eases) in easecontrol study. NSAIDs were stopped during treatment. Patients in Hp eradication group were treated with Omeprazole (Losec) 20mg Bid, Clarithromyein 0. 5 Bid, Amoxieilline 1.0 Bid for one week, then Omeprazole 20mg qid for 8 weeks. Patients in antiaeid group were treated with Omeprazole 20mg qid for 8 weeks. All patients were given endoscopies and Hp examinations in 1 month and 24 months. The cure rate, recurrent rate and complication rate were compared between the two groups. Results The eradication rate of Hp eradication group was 98%, the cure rates of the two groups had no significant difference (85.7% ,88.0~~ ,P^0.05). The ulcer recurrent rate in 2 years in antacid group was significantly lower than that in Hp eradication group (12% ,26.5%, P〈0.05). Incidence of bleeding gastric ulcers in antacid group was significantly lower than that in Hp eradication group (15. 5% ,28.1% ,P〈0.05). Incidences of bleeding duodenal ulcers had no significant difference in two groups (9.5%, 10. 7% ,P〉0.05). Conclusion Hp and NSAIDs are two independent risk factors of peptic ulcer, they wont work in cooperation. NSAIDs peptic ulcer doesn't affect by Hp infection, and the presence of Hp is associated with a lower risk of short - term recurrence. There is a negative interaction between Hp and NSAID used in patients with bleeding gastric ulcer, but no interaction is found between Hp and bleeding duodenal ulcer.
出处 《中国煤炭工业医学杂志》 2007年第7期762-763,共2页 Chinese Journal of Coal Industry Medicine
关键词 幽门螺杆菌感染 非甾体类抗炎药 消化性溃疡 转归 H. pylori (Hp) infection non- steroidal anti- infiammatory drug (NSAID) peptic ulcer outcome
  • 相关文献

参考文献7

  • 1王琳.溃疡愈合质量与复发[J].胃肠病学和肝病学杂志,2000,9(4):246-249. 被引量:11
  • 2Silverstein FE.Improving the gastrointestinal safety of NSAIDs the development of misoprostol from hypothesis to clinical practice[J].Dig Dis Sci,1998,43:449-458
  • 3Champion GD,Feng PH,Azuma T,et al.NSAID-induced gastrointestinal damage.Epidemiology,risk and prevention with an evaluation of the role of misoprostol[J].An Asia-Pacific perapective and consensus Drugs,1997,53:6-9
  • 4Hawkey CJ.Nonsteroidal anti-inflammatory drug gastropathy[J].Gastroenterology,2000,119:521-535
  • 5崔忠敏,李兆申,许国铭.幽门螺杆菌感染与非甾体类抗炎药胃十二指肠黏膜损伤关系的研究进展[J].胃肠病学,2002,7(5):309-314. 被引量:5
  • 6Wu CY,Poon SK,Chen GH,et al.Interaction between H.pylori and non-steroidal anti-inflammatory dugys in peptic ulcers bleeding[J].Scand J Gastroenteral,1999,34:234-237
  • 7Alherto Pilotto MD.Role of H.pylori infection on upper gastrointestinal bleeding in the elderly[J].Digesive Diseases and Sciences,1997,42(3):586-591

二级参考文献59

  • 1杨雪松,李益农.溃疡愈合质量的研究现状[J].中华内科杂志,1995,34(4):270-276. 被引量:46
  • 2Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, Borsch G, Blum AL, Helicobacter pylori augments the pH-increasing effect ofomeprazole in patients with duodenal ulcer. Gastroenterology, 1996, 110: 725~732.
  • 3Verdu EF, Armstrong D, Idstrom JP, Labenz J,Stolte M, Dorta G, Borsch G, Blum AL. Effect ofcuring Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut,1995, 37: 743~748.
  • 4Hawkey CJ. Is Helicobacter pylori eradication useful in patients taking NSAIDs? Eur J Gastroenterol Hepatol, 1999, 11 Suppl 2: S47~S50.
  • 5Hawkey CJ, Tulassay Z, Szczepanski L, vanRensburg CJ, Filipowicz-Sosnowska A, Lanas A,Wason CM, Peacock RA, Gillon KR. Randomisedcontrolled trial of Helicobacter pylori eradicationin patients on non-steroidal anti-inflammatorydrugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet, 1998, 352:1016 ~ 1021.
  • 6Konturek JW, Konturek SJ, Stachura J, Domschke W. Helicobacter pylori-positive peptic ulcerpatients do not adapt to aspirin. Aliment Pharmacol Ther, 1998, 12: 857~864.
  • 7Lipscomb GR, Campbell F, Rees WD. The influence of age, gender, Helicobacter pylori andsmoking on gastric mucosal adaptation to nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther, 1997, 11: 907~912.
  • 8Lauwers GY, Furman J, Michael LE, Balis UJ,Kubilis PS. Cytoskeletal and kinetic epithelialdifferences between NSAID gastropathy and Helicobacter pylori gastritis: an immunohistochemicaldetermination. Histopathology, 2001, 39: 133~140.
  • 9Cappell MS, Schein JR. Diagnosis and treatmentof nonsteroidal anti-inflammatory drug-associatedupper gastrointestinal toxicity. Gastroenterol ClinNorth Am, 2000, 29: 97~124.
  • 10Champion GD, Feng PH, Azuma T, Caughey DE,Chan KH, Kashiwazaki S, Liu HC, Nasution AR,Nobunaga M, Prichanond S, Torralba TP, UdomV, Utis D, Wang SR, Wong WS, Yang DJ, YooMC. NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacificperspective and consensus. Drugs, 1997, 53: 6~19.

共引文献13

同被引文献16

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部